ClinicalTrials.gov
ClinicalTrials.gov Menu

Internet-delivered Psychodynamic Therapy for Depression

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01324050
Recruitment Status : Completed
First Posted : March 28, 2011
Last Update Posted : August 2, 2011
Sponsor:
Information provided by:
Linkoeping University

Brief Summary:
The overall aim of this study is to develop and test a psychodynamic Internet-delivered psychological treatment for patients with mild to moderate major depression and compare its efficacy to an active control group.

Condition or disease Intervention/treatment Phase
Depression Behavioral: Internet-delivered psychodynamic therapy for depression Behavioral: Internet-delivered therapist support Not Applicable

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 92 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Internet-delivered Psychodynamic Therapy for Depression: a Randomized Controlled Trial
Study Start Date : February 2011
Actual Primary Completion Date : May 2011
Actual Study Completion Date : May 2011

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: Internet-based Psychodynamic Therapy Behavioral: Internet-delivered psychodynamic therapy for depression
This intervention contains 9 text-based self-help modules. These modules contain material inspired by psychoanalytic theory about identifying reoccurring patterns in life among other things. In addition to the self-help modules, 10-15 minutes of therapist contact is given every week. In total, the intervention will last for 10 weeks.

Active Comparator: Internet-delivered therapist support Behavioral: Internet-delivered therapist support
This intervention contains 1 text-based self-help module, which is mainly based on information on depression. In addition to this text, the participants in this group gets 10-15 minutes of therapist contact every week. In the conversation with the therapist, the participant informs the therapist about the activities during the week. This intervention is considered to be a form of support. In total, the intervention will last for 10 weeks.




Primary Outcome Measures :
  1. Beck Depression Inventory (BDI) [ Time Frame: Two weeks before the treatment starts ]
  2. Beck Depression Inventory (BDI) [ Time Frame: At treatment start (0 weeks) ]
  3. Beck Depression Inventory (BDI) [ Time Frame: At treatment termination (10 weeks) ]

Secondary Outcome Measures :
  1. Beck Anxiety Inventory (BAI) [ Time Frame: Two weeks before the treatment starts ]
  2. Beck Anxiety Inventory (BAI) [ Time Frame: At treatment termination (10 weeks) ]
  3. Montgomery Åsberg Depression Rating Scale Self-report (MADRS-S) [ Time Frame: Two weeks before treatment starts ]
  4. Montgomery Åsberg Depression Rating Scale Self-report (MADRS-S) [ Time Frame: At treatment termination (10 weeks) ]
  5. Quality of Life Inventory (QOLI) [ Time Frame: Two weeks before treatment starts ]
  6. Quality of Life Inventory (QOLI) [ Time Frame: At treatment termination (10 weeks) ]
  7. Patient Health Questionnaire 9 (PHQ-9) [ Time Frame: Two weeks before treatment starts ]
  8. Patient Health Questionnaire 9 (PHQ-9) [ Time Frame: At treatment termination (10 weeks) ]
  9. Generalised Anxiety Disorder Assessment 7 (GAD-7) [ Time Frame: Two weeks before treatment starts ]
  10. Generalised Anxiety Disorder Assessment 7 (GAD-7) [ Time Frame: At treatment termination (10 weeks) ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 80 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Clinical diagnosis of Major Depressive Disorder
  • 15 or more on MADRS-S

Exclusion Criteria:

  • Severe depression (more than 35 on MADRS-S or based on interview)
  • Severe psychiatric condition (e.g. psychosis or bipolar disorder)
  • Suicidal (measured in diagnostic interview)
  • Changed medication during the last three months

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01324050


Locations
Sweden
Linköping University, Department of Behavioral Sciences and Learning
Linköping, Sweden
Linköping University
Linköping, Sweden
Sponsors and Collaborators
Linkoeping University
Investigators
Principal Investigator: Gerhard Andersson, PhD Department of Behavioral Sciences and Learning, Linköping University